Industry Research Reports
Home > Reports > New Technology > Global Kidney-Organ Chip Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Global Kidney-Organ Chip Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Key Findings
In 2025, global production of Kidney-Organ Chip was approximately 22,599 units.
Commercial models concentrate on proximal tubule and nephrotoxicity applications
Human cells and controlled perfusion improve renal physiological relevance
Drug developers and research institutions remain the primary customer groups
Assay-ready systems reduce operational barriers for pharmaceutical laboratories
Standardization and regulatory validation determine long-term market scalability
Kidney-Organ Chip Market Size(US$)
CAGR 2026-2032
10.5%
Market Size,2032
USD 73.18
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 40.18 million
Market Forecast in 2032(Value)
US$ 73.18 million
CAGR
10.5%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Kidney-Organ Chip market size was US$ 35.29 million in 2025 and is forecast to reach a readjusted size of US$ 73.18 million by 2032 with a CAGR of 10.5% during the forecast period 2026-2032.
A Kidney-Organ Chip, more commonly described as a Kidney Organ-on-a-Chip, is a microengineered in vitro platform designed to reproduce selected structural, mechanical, and physiological characteristics of the human kidney. The system combines human renal cells with microfluidic channels, porous membranes, extracellular matrices, controlled perfusion, and biochemical stimulation to simulate kidney functions under dynamic conditions. Depending on the model design, it may replicate the glomerular filtration barrier, proximal-tubule secretion and reabsorption, distal-tubule transport, collecting-duct function, renal vasculature, or interactions among several nephron segments. Kidney-Organ Chips are primarily used in nephrotoxicity testing, renal disease modeling, drug transport and clearance studies, pharmacokinetic research, and development of personalized therapies. The market scope includes blank microfluidic chips, cell-loaded assay-ready models, kidney organoid-on-chip products, perfusion instruments, pumps, sensors, culture media, cells, software, analytical services, customized model development, training, and maintenance. These products are laboratory research and drug-development tools rather than implantable chips, dialysis systems, or therapeutic artificial kidneys.
Market Trends
Kidney-Organ Chip technology is progressing from basic single-channel cell-culture devices toward multicellular, vascularized, organoid-based, and interconnected renal models. Developers increasingly use human primary cells, immortalized renal cell lines, induced pluripotent stem-cell-derived cells, and adult stem-cell-derived organoids to improve physiological relevance. Dynamic perfusion and controlled shear stress support cell polarity, transporter expression, and long-term renal function. Another major trend is the development of standardized, microplate-compatible products that support automated liquid handling, high-content imaging, and medium- to high-throughput compound testing. Cell-loaded assay-ready models are becoming more important because they reduce model-establishment time and operator-dependent variability. Integrated sensors, real-time imaging, artificial-intelligence-assisted analysis, and transcriptomic or proteomic measurements are expanding functional readouts. Multi-organ configurations linking the kidney with the liver, intestine, heart, muscle, or immune system are also gaining attention for evaluating drug metabolism, systemic exposure, renal clearance, and inter-organ toxicity. These developments are gradually moving Kidney-Organ Chips from academic prototypes toward practical preclinical tools.
Market Segmentation
By Company
- Emulate
- Mimetas
- TissUse
- Valo Health
- CN Bio Innovations
- Draper Laboratory
- Nortis
- Xona Microfluidics
- SynVivo
- Beijing Daxiang Biotech
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Glomerular Chip
- Renal Tubule Chip
- Colliding Duct Chip
Segment by Application
- Hospitals
- Research Institutions
- Universities
- Others
Segment by Category
- Membrane-Based Dual-Channel Type
- 3D Matrix-Embedded Tubular Type
Segment by Division
- Primary Human Cell-Based Type
- Immortalized Cell Line-Based Type
- Stem Cell & Organoid-Based Type
Market Dynamics
Drivers
The primary market driver is the need to detect drug-induced kidney injury earlier and more accurately during pharmaceutical development. Renal toxicity can result in program termination, clinical failure, restricted dosing, additional monitoring requirements, or post-market safety concerns. Conventional models may not reproduce the polarity, transporter activity, fluid flow, and epithelial-vascular interactions of the human kidney. Kidney-Organ Chips provide controlled environments for measuring drug exposure, secretion, reabsorption, permeability, biomarker release, and tissue injury over time. Growing research activity in acute kidney injury, chronic kidney disease, diabetic nephropathy, polycystic kidney disease, fibrosis, infection, and inherited renal disorders is also expanding demand for human disease models. Additional growth factors include advances in microfluidics, stem-cell differentiation, organoid culture, three-dimensional tissue engineering, and automated imaging. Policies promoting alternatives to animal testing and pharmaceutical investment in human-relevant models further support adoption. Together, these drivers are extending Kidney-Organ Chip use from academic research to mechanistic toxicology, compound screening, translational studies, and preclinical decision support.
Restraints
Commercial expansion is restrained by the biological complexity of the kidney and the lack of universally accepted validation standards. The kidney contains multiple nephron segments, specialized epithelial cells, endothelial cells, stromal cells, immune components, and complex vascular structures responsible for filtration, secretion, reabsorption, concentration, and endocrine regulation. Most commercial models reproduce only selected functions rather than the complete organ. Human primary renal cells may exhibit donor variability and limited expansion, while immortalized or stem-cell-derived cells may not fully achieve adult tissue maturity. Microfluidic systems may experience bubbles, evaporation, contamination, inconsistent flow, material absorption, and operational complexity. Customers can also require specialized pumps, imaging equipment, analytical methods, and trained personnel. Differences in chip geometry, cell type, extracellular matrix, medium, flow rate, exposure protocol, and endpoint selection reduce comparability between platforms. Until reference compounds, performance criteria, interlaboratory studies, and regulatory pathways become more established, Kidney-Organ Chips will mainly complement rather than completely replace existing preclinical methods.
Opportunities
The strongest commercial opportunities lie in standardized and assay-ready Kidney-Organ Chip models that provide reproducible results with limited user preparation. Pharmaceutical companies require scalable platforms for nephrotoxicity screening, renal transporter analysis, biomarker assessment, compound prioritization, and mechanism-of-injury studies. Disease-specific models constructed from patient-derived cells or induced pluripotent stem cells offer opportunities in rare kidney diseases, inherited disorders, precision medicine, and individualized therapeutic development. Multi-organ systems connecting the kidney with the liver, intestine, muscle, heart, or immune system can support pharmacokinetic, metabolism, systemic toxicity, and organ-interaction studies. Suppliers can also expand through customized model development, contract testing, data analysis, regulatory consulting, software, training, and cell-and-reagent packages. Compatibility with automated laboratory workflows and standard microplate formats could accelerate adoption by large pharmaceutical organizations. China, Japan, and South Korea offer additional opportunities through expanding biopharmaceutical research, microfluidic manufacturing capabilities, organoid programs, and policies supporting alternatives to animal testing. Partnerships with contract research organizations and cell suppliers can further strengthen market access.
Challenges
The principal challenge is generating biologically meaningful and repeatable data suitable for pharmaceutical and regulatory decisions. Renal cells must maintain appropriate polarity, transporter expression, barrier integrity, metabolic activity, and responses to physiological flow throughout the required culture period. Variations in cell source, extracellular matrix, medium composition, chip material, flow conditions, and dosing procedures can materially affect results. Developers must also establish clinically relevant endpoints, including transport activity, permeability, morphology, gene expression, tissue-injury biomarkers, and recovery responses. Scaling from laboratory prototypes to standardized commercial products requires consistent microfabrication, membrane quality, surface treatment, sterilization, cell loading, packaging, storage, and shipment. Another challenge is balancing physiological complexity with throughput and operational simplicity. Highly complex vascularized or multi-organ models may offer stronger biological relevance but can be more difficult and expensive to operate. Wider adoption will require reference-compound testing, transparent performance benchmarks, standardized data formats, interlaboratory validation, and clearer regulatory acceptance of Kidney-Organ Chip evidence.
Industry Chain Analysis
The upstream industry includes microfluidic polymers, glass substrates, porous membranes, extracellular matrices, surface coatings, renal cells, stem cells, organoids, culture media, growth factors, pumps, valves, tubing, sensors, imaging systems, and laboratory automation equipment. The quality of these inputs directly influences cell viability, flow stability, optical performance, compound absorption, and experimental reproducibility. Midstream companies design and manufacture microfluidic chips, integrate perfusion equipment, construct renal tissue models, optimize culture protocols, develop analytical software, validate biological functions, and provide assay-ready products or customized testing services. Their competitiveness depends on combining microengineering, cell biology, tissue engineering, pharmacology, and data analysis. Downstream customers include pharmaceutical and biotechnology companies, contract research organizations, universities, hospitals, government laboratories, chemical companies, cosmetics companies, and regulatory research institutions. Products reach customers through direct technical sales, specialized scientific distributors, collaborative development agreements, and contract-service models. Installation, training, model development, data interpretation, software support, and consumable supply constitute an important service layer.
Segment Insights
By simulated renal structure, Kidney-Organ Chips can be divided into glomerulus-on-chip, proximal-tubule-on-chip, distal-tubule or collecting-duct models, and integrated nephron or multi-organ systems. Proximal-tubule models represent the most commercially developed segment because they support nephrotoxicity, secretion, reabsorption, and transporter studies. By technical architecture, the market includes membrane-based dual-channel devices, three-dimensional matrix-embedded tubular models, organoid-on-chip platforms, vascularized renal models, and bioprinted chips. By product form, products can be classified into blank chips and consumables, cell-loaded assay-ready models, perfusion instruments and complete systems, and customized testing services. By cell source, models use primary human renal cells, immortalized cell lines, induced pluripotent stem-cell-derived cells, or adult stem-cell-derived organoids. Major applications include drug-induced nephrotoxicity testing, renal disease modeling, drug transport and clearance studies, pharmacokinetic and ADME analysis, and personalized medicine. Selection depends on biological complexity, throughput, repeatability, operating difficulty, and required analytical endpoints.
Downstream Market Opportunities
Drug-induced nephrotoxicity testing represents the leading downstream opportunity because pharmaceutical developers need to identify compounds that damage glomerular, tubular, vascular, or interstitial tissues before clinical trials. Kidney-Organ Chips can support dose-response analysis, compound ranking, transporter studies, biomarker evaluation, and investigation of injury mechanisms. Renal disease modeling offers opportunities in acute kidney injury, chronic kidney disease, diabetic nephropathy, polycystic kidney disease, fibrosis, infection, and inherited disorders. Drug-transport and clearance models can improve understanding of secretion, reabsorption, metabolite handling, and drug-drug interactions. Multi-organ systems enable analysis of metabolites generated by the liver, substances absorbed through the intestine, and systemic toxicity involving the kidney and other tissues. Patient-derived cells and kidney organoids create longer-term opportunities in precision medicine and individualized therapy selection. Pharmaceutical companies, biotechnology firms, contract research organizations, and academic institutions are the primary customers, while chemical, cosmetics, food, and environmental-safety organizations represent additional demand for renal toxicity assessment.
Regional Insights
North America is an important center for Kidney-Organ Chip commercialization, pharmaceutical adoption, academic research, and regulatory collaboration, supported by companies such as Emulate, Nortis, Hesperos, and Creative Biolabs. Europe has also established a strong position in organ-on-a-chip platforms, with MIMETAS, TissUse, CN Bio, Kirkstall, BEOnChip, InSphero, and Fluigent participating in kidney models, multi-organ systems, perfusion equipment, or enabling technologies. The region benefits from established pharmaceutical research, microfluidics expertise, and policies supporting non-animal testing. Asia-Pacific is developing rapidly as China, Japan, and South Korea increase investment in organoid technologies, microphysiological systems, drug-safety evaluation, and domestic laboratory equipment. Beijing Daxiang Biotech is active in organoid-chip models in China, while Nanosystems Japan and EDmicBio participate in microfluidic fabrication and three-dimensional organ-chip development. Regional expansion will depend on pharmaceutical partnerships, local cell resources, technical-service networks, regulatory validation, and the availability of trained users.
Fastest-Growing Region: Asia Pacific
North America is an important center for Kidney-Organ Chip commercialization, pharmaceutical adoption, academic research, and regulatory collaboration, supported by companies such as Emulate, Nortis, Hesperos, and Creative Biolabs. Europe has also established a strong position in organ-on-a-chip platforms, with MIMETAS, TissUse, CN Bio, Kirkstall, BEOnChip, InSphero, and Fluigent participating in kidney models, multi-organ systems, perfusion equipment, or enabling technologies. The region benefits from established pharmaceutical research, microfluidics expertise, and policies supporting non-animal testing. Asia-Pacific is developing rapidly as China, Japan, and South Korea increase investment in organoid technologies, microphysiological systems, drug-safety evaluation, and domestic laboratory equipment. Beijing Daxiang Biotech is active in organoid-chip models in China, while Nanosystems Japan and EDmicBio participate in microfluidic fabrication and three-dimensional organ-chip development. Regional expansion will depend on pharmaceutical partnerships, local cell resources, technical-service networks, regulatory validation, and the availability of trained users.
- XX.X%CAGR*
- XXXXUS$ Million
- XXXXREGIONAL SHARE
By Type,2021-2032(US$ Million)
Glomerular Chip
Renal Tubule Chip
Colliding Duct Chip
By Application，2021-2032(US$ Million）
Hospitals
Research Institutions
Universities
Others
Competitive Landscape Analysis
The competitive landscape includes dedicated Kidney-Organ Chip suppliers, broader organ-on-a-chip platform companies, perfusion-system manufacturers, microfluidic-device producers, and contract model-development providers. Emulate offers a validated Kidney-Chip model, while MIMETAS provides perfused kidney models and kidney organoid tubules through its OrganoPlate platform. Nortis is recognized for proximal-tubule chips, and TissUse develops kidney-containing multi-organ systems. CN Bio and Hesperos provide platforms capable of incorporating kidney tissues into single- or multi-organ studies. Creative Biolabs offers customized Kidney-Organ Chip development, while Kirkstall, BEOnChip, InSphero, Fluigent, and Microfluidics Innovation Center provide adaptable organ-chip, perfusion, or renal-model solutions. Asian participants include Beijing Daxiang Biotech, Nanosystems Japan, and EDmicBio. Competitive differentiation centers on renal physiological relevance, validated function, reproducibility, throughput, ease of use, cell quality, automation, data analysis, application support, and regulatory credibility rather than on microfluidic-chip production capacity alone.
Report Scope
The global Kidney-Organ Chip market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of Kidney-Organ Chip market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Kidney-Organ Chip value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYResearch's Strengths
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Glomerular Chip
1.2.3 Renal Tubule Chip
1.2.4 Colliding Duct Chip
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Hospitals
1.3.3 Research Institutions
1.3.4 Universities
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Kidney-Organ Chip Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Kidney-Organ Chip Market Share by Revenue, by Region (2021-2026)
2.4 Global Kidney-Organ Chip Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Kidney-Organ Chip Market Size and Prospective (2021-2032)
2.5.2 Europe Kidney-Organ Chip Market Size and Prospective (2021-2032)
2.5.3 China Kidney-Organ Chip Market Size and Prospective (2021-2032)
2.5.4 Japan Kidney-Organ Chip Market Size and Prospective (2021-2032)
3 Breakdown Data by Type
3.1 Global Kidney-Organ Chip Historical Market Size by Type (2021-2026)
3.2 Global Kidney-Organ Chip Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Kidney-Organ Chip
4 Breakdown Data by Application
4.1 Global Kidney-Organ Chip Historical Market Size by Application (2021-2026)
4.2 Global Kidney-Organ Chip Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Kidney-Organ Chip Applications
5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Kidney-Organ Chip Players by Revenue (2021-2026)
5.1.2 Global Kidney-Organ Chip Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Kidney-Organ Chip Revenue
5.4 Global Kidney-Organ Chip Market Concentration Analysis
5.4.1 Global Kidney-Organ Chip Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Kidney-Organ Chip Revenue in 2025
5.5 Global Key Players of Kidney-Organ Chip Head Offices and Areas Served
5.6 Global Key Players of Kidney-Organ Chip, Product and Application
5.7 Global Key Players of Kidney-Organ Chip, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Kidney-Organ Chip Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Kidney-Organ Chip Market Size by Type (2021-2026)
6.1.2.2 North America Kidney-Organ Chip Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Kidney-Organ Chip Market Size by Application (2021-2026)
6.1.3.2 North America Kidney-Organ Chip Market Share by Application (2021-2026)
6.1.4 North America Kidney-Organ Chip Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Kidney-Organ Chip Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Kidney-Organ Chip Market Size by Type (2021-2026)
6.2.2.2 Europe Kidney-Organ Chip Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Kidney-Organ Chip Market Size by Application (2021-2026)
6.2.3.2 Europe Kidney-Organ Chip Market Share by Application (2021-2026)
6.2.4 Europe Kidney-Organ Chip Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Kidney-Organ Chip Revenue by Company (2021-2026)
6.3.2 China Market Size by Type
6.3.2.1 China Kidney-Organ Chip Market Size by Type (2021-2026)
6.3.2.2 China Kidney-Organ Chip Market Share by Type (2021-2026)
6.3.3 China Market Size by Application
6.3.3.1 China Kidney-Organ Chip Market Size by Application (2021-2026)
6.3.3.2 China Kidney-Organ Chip Market Share by Application (2021-2026)
6.3.4 China Kidney-Organ Chip Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Kidney-Organ Chip Revenue by Company (2021-2026)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Kidney-Organ Chip Market Size by Type (2021-2026)
6.4.2.2 Japan Kidney-Organ Chip Market Share by Type (2021-2026)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Kidney-Organ Chip Market Size by Application (2021-2026)
6.4.3.2 Japan Kidney-Organ Chip Market Share by Application (2021-2026)
6.4.4 Japan Kidney-Organ Chip Major Customers
6.4.5 Japan Market Trends and Opportunities
7 Key Player Profiles
7.1 Emulate
7.1.1 Emulate Company Details
7.1.2 Emulate Business Overview
7.1.3 Emulate Kidney-Organ Chip Introduction
7.1.4 Emulate Revenue in Kidney-Organ Chip Business (2021-2026)
7.1.5 Emulate Recent Development
7.2 Mimetas
7.2.1 Mimetas Company Details
7.2.2 Mimetas Business Overview
7.2.3 Mimetas Kidney-Organ Chip Introduction
7.2.4 Mimetas Revenue in Kidney-Organ Chip Business (2021-2026)
7.2.5 Mimetas Recent Development
7.3 TissUse
7.3.1 TissUse Company Details
7.3.2 TissUse Business Overview
7.3.3 TissUse Kidney-Organ Chip Introduction
7.3.4 TissUse Revenue in Kidney-Organ Chip Business (2021-2026)
7.3.5 TissUse Recent Development
7.4 Valo Health
7.4.1 Valo Health Company Details
7.4.2 Valo Health Business Overview
7.4.3 Valo Health Kidney-Organ Chip Introduction
7.4.4 Valo Health Revenue in Kidney-Organ Chip Business (2021-2026)
7.4.5 Valo Health Recent Development
7.5 CN Bio Innovations
7.5.1 CN Bio Innovations Company Details
7.5.2 CN Bio Innovations Business Overview
7.5.3 CN Bio Innovations Kidney-Organ Chip Introduction
7.5.4 CN Bio Innovations Revenue in Kidney-Organ Chip Business (2021-2026)
7.5.5 CN Bio Innovations Recent Development
7.6 Draper Laboratory
7.6.1 Draper Laboratory Company Details
7.6.2 Draper Laboratory Business Overview
7.6.3 Draper Laboratory Kidney-Organ Chip Introduction
7.6.4 Draper Laboratory Revenue in Kidney-Organ Chip Business (2021-2026)
7.6.5 Draper Laboratory Recent Development
7.7 Nortis
7.7.1 Nortis Company Details
7.7.2 Nortis Business Overview
7.7.3 Nortis Kidney-Organ Chip Introduction
7.7.4 Nortis Revenue in Kidney-Organ Chip Business (2021-2026)
7.7.5 Nortis Recent Development
7.8 Xona Microfluidics
7.8.1 Xona Microfluidics Company Details
7.8.2 Xona Microfluidics Business Overview
7.8.3 Xona Microfluidics Kidney-Organ Chip Introduction
7.8.4 Xona Microfluidics Revenue in Kidney-Organ Chip Business (2021-2026)
7.8.5 Xona Microfluidics Recent Development
7.9 SynVivo
7.9.1 SynVivo Company Details
7.9.2 SynVivo Business Overview
7.9.3 SynVivo Kidney-Organ Chip Introduction
7.9.4 SynVivo Revenue in Kidney-Organ Chip Business (2021-2026)
7.9.5 SynVivo Recent Development
7.10 Beijing Daxiang Biotech
7.10.1 Beijing Daxiang Biotech Company Details
7.10.2 Beijing Daxiang Biotech Business Overview
7.10.3 Beijing Daxiang Biotech Kidney-Organ Chip Introduction
7.10.4 Beijing Daxiang Biotech Revenue in Kidney-Organ Chip Business (2021-2026)
7.10.5 Beijing Daxiang Biotech Recent Development
8 Kidney-Organ Chip Market Dynamics
8.1 Kidney-Organ Chip Industry Trends
8.2 Kidney-Organ Chip Market Drivers
8.3 Kidney-Organ Chip Market Challenges
8.4 Kidney-Organ Chip Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Kidney-Organ Chip Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global Kidney-Organ Chip Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market Kidney-Organ Chip Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global Kidney-Organ Chip Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global Kidney-Organ Chip Revenue Share by Region (2021-2026)
Table 6. Global Kidney-Organ Chip Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global Kidney-Organ Chip Revenue Share Forecast by Region (2027-2032)
Table 8. Global Kidney-Organ Chip Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global Kidney-Organ Chip Market Share by Revenue, by Type (2021-2026)
Table 10. Global Kidney-Organ Chip Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global Kidney-Organ Chip Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global Kidney-Organ Chip Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global Kidney-Organ Chip Market Share by Revenue, by Application (2021-2026)
Table 15. Global Kidney-Organ Chip Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global Kidney-Organ Chip Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in Kidney-Organ Chip Applications
Table 18. Global Kidney-Organ Chip Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global Kidney-Organ Chip Market Share by Players (2021-2026)
Table 20. Global Top Kidney-Organ Chip Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney-Organ Chip as of 2025)
Table 21. Ranking of Global Top Kidney-Organ Chip Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Kidney-Organ Chip Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of Kidney-Organ Chip, Headquarters and Area Served
Table 24. Global Key Players of Kidney-Organ Chip, Product and Application
Table 25. Global Key Players of Kidney-Organ Chip, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Kidney-Organ Chip Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America Kidney-Organ Chip Market Share by Revenue, by Company (2021-2026)
Table 29. North America Kidney-Organ Chip Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America Kidney-Organ Chip Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe Kidney-Organ Chip Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe Kidney-Organ Chip Market Share by Revenue, by Company (2021-2026)
Table 33. Europe Kidney-Organ Chip Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe Kidney-Organ Chip Market Size by Application (2021-2026) & (US$ Million)
Table 35. China Kidney-Organ Chip Revenue by Company (2021-2026) & (US$ Million)
Table 36. China Kidney-Organ Chip Market Share by Revenue, by Company (2021-2026)
Table 37. China Kidney-Organ Chip Market Size by Type (2021-2026) & (US$ Million)
Table 38. China Kidney-Organ Chip Market Size by Application (2021-2026) & (US$ Million)
Table 39. Japan Kidney-Organ Chip Revenue by Company (2021-2026) & (US$ Million)
Table 40. Japan Kidney-Organ Chip Market Share by Revenue, by Company (2021-2026)
Table 41. Japan Kidney-Organ Chip Market Size by Type (2021-2026) & (US$ Million)
Table 42. Japan Kidney-Organ Chip Market Size by Application (2021-2026) & (US$ Million)
Table 43. Emulate Company Details
Table 44. Emulate Business Overview
Table 45. Emulate Kidney-Organ Chip Product
Table 46. Emulate Revenue in Kidney-Organ Chip Business (2021-2026) & (US$ Million)
Table 47. Emulate Recent Development
Table 48. Mimetas Company Details
Table 49. Mimetas Business Overview
Table 50. Mimetas Kidney-Organ Chip Product
Table 51. Mimetas Revenue in Kidney-Organ Chip Business (2021-2026) & (US$ Million)
Table 52. Mimetas Recent Development
Table 53. TissUse Company Details
Table 54. TissUse Business Overview
Table 55. TissUse Kidney-Organ Chip Product
Table 56. TissUse Revenue in Kidney-Organ Chip Business (2021-2026) & (US$ Million)
Table 57. TissUse Recent Development
Table 58. Valo Health Company Details
Table 59. Valo Health Business Overview
Table 60. Valo Health Kidney-Organ Chip Product
Table 61. Valo Health Revenue in Kidney-Organ Chip Business (2021-2026) & (US$ Million)
Table 62. Valo Health Recent Development
Table 63. CN Bio Innovations Company Details
Table 64. CN Bio Innovations Business Overview
Table 65. CN Bio Innovations Kidney-Organ Chip Product
Table 66. CN Bio Innovations Revenue in Kidney-Organ Chip Business (2021-2026) & (US$ Million)
Table 67. CN Bio Innovations Recent Development
Table 68. Draper Laboratory Company Details
Table 69. Draper Laboratory Business Overview
Table 70. Draper Laboratory Kidney-Organ Chip Product
Table 71. Draper Laboratory Revenue in Kidney-Organ Chip Business (2021-2026) & (US$ Million)
Table 72. Draper Laboratory Recent Development
Table 73. Nortis Company Details
Table 74. Nortis Business Overview
Table 75. Nortis Kidney-Organ Chip Product
Table 76. Nortis Revenue in Kidney-Organ Chip Business (2021-2026) & (US$ Million)
Table 77. Nortis Recent Development
Table 78. Xona Microfluidics Company Details
Table 79. Xona Microfluidics Business Overview
Table 80. Xona Microfluidics Kidney-Organ Chip Product
Table 81. Xona Microfluidics Revenue in Kidney-Organ Chip Business (2021-2026) & (US$ Million)
Table 82. Xona Microfluidics Recent Development
Table 83. SynVivo Company Details
Table 84. SynVivo Business Overview
Table 85. SynVivo Kidney-Organ Chip Product
Table 86. SynVivo Revenue in Kidney-Organ Chip Business (2021-2026) & (US$ Million)
Table 87. SynVivo Recent Development
Table 88. Beijing Daxiang Biotech Company Details
Table 89. Beijing Daxiang Biotech Business Overview
Table 90. Beijing Daxiang Biotech Kidney-Organ Chip Product
Table 91. Beijing Daxiang Biotech Revenue in Kidney-Organ Chip Business (2021-2026) & (US$ Million)
Table 92. Beijing Daxiang Biotech Recent Development
Table 93. Kidney-Organ Chip Market Trends
Table 94. Kidney-Organ Chip Market Drivers
Table 95. Kidney-Organ Chip Market Challenges
Table 96. Kidney-Organ Chip Market Restraints
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Kidney-Organ Chip Product Picture
Figure 2. Global Kidney-Organ Chip Market Share by Type: 2025 vs 2032
Figure 3. Glomerular Chip Features
Figure 4. Renal Tubule Chip Features
Figure 5. Colliding Duct Chip Features
Figure 6. Global Kidney-Organ Chip Market Share by Application: 2025 vs 2032
Figure 7. Hospitals
Figure 8. Research Institutions
Figure 9. Universities
Figure 10. Others
Figure 11. Kidney-Organ Chip Report Years Considered
Figure 12. Global Kidney-Organ Chip Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 13. Global Kidney-Organ Chip Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Kidney-Organ Chip Market Share by Revenue, by Region: 2021 vs 2025
Figure 15. North America Kidney-Organ Chip Revenue (US$ Million) Growth Rate (2021-2032)
Figure 16. Europe Kidney-Organ Chip Revenue (US$ Million) Growth Rate (2021-2032)
Figure 17. China Kidney-Organ Chip Revenue (US$ Million) Growth Rate (2021-2032)
Figure 18. Japan Kidney-Organ Chip Revenue (US$ Million) Growth Rate (2021-2032)
Figure 19. Global Kidney-Organ Chip Market Share by Players in 2025
Figure 20. Global Top Kidney-Organ Chip Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney-Organ Chip as of 2025)
Figure 21. The Top 10 and 5 Players Market Share by Kidney-Organ Chip Revenue in 2025
Figure 22. North America Kidney-Organ Chip Market Share by Type (2021-2026)
Figure 23. North America Kidney-Organ Chip Market Share by Application (2021-2026)
Figure 24. Europe Kidney-Organ Chip Market Share by Type (2021-2026)
Figure 25. Europe Kidney-Organ Chip Market Share by Application (2021-2026)
Figure 26. China Kidney-Organ Chip Market Share by Type (2021-2026)
Figure 27. China Kidney-Organ Chip Market Share by Application (2021-2026)
Figure 28. Japan Kidney-Organ Chip Market Share by Type (2021-2026)
Figure 29. Japan Kidney-Organ Chip Market Share by Application (2021-2026)
Figure 30. Emulate Revenue Growth Rate in Kidney-Organ Chip Business (2021-2026)
Figure 31. Mimetas Revenue Growth Rate in Kidney-Organ Chip Business (2021-2026)
Figure 32. TissUse Revenue Growth Rate in Kidney-Organ Chip Business (2021-2026)
Figure 33. Valo Health Revenue Growth Rate in Kidney-Organ Chip Business (2021-2026)
Figure 34. CN Bio Innovations Revenue Growth Rate in Kidney-Organ Chip Business (2021-2026)
Figure 35. Draper Laboratory Revenue Growth Rate in Kidney-Organ Chip Business (2021-2026)
Figure 36. Nortis Revenue Growth Rate in Kidney-Organ Chip Business (2021-2026)
Figure 37. Xona Microfluidics Revenue Growth Rate in Kidney-Organ Chip Business (2021-2026)
Figure 38. SynVivo Revenue Growth Rate in Kidney-Organ Chip Business (2021-2026)
Figure 39. Beijing Daxiang Biotech Revenue Growth Rate in Kidney-Organ Chip Business (2021-2026)
Figure 40. Bottom-up and Top-down Approaches for This Report
Figure 41. Data Triangulation
Figure 42. Key Executives Interviewed
Related Reports
Global Kidney-Organ Chip Market Research Report 2024
A Kidney-Organ Chip, often referred to as a "kidney chip," is a microfluidic device designed to replicate the structure and function of the human kidney on a miniature scale. It is a type of organ-on-a-chip technology used in biomedical research and drug development. The Kidney-on-a-Chip model aims to mimic the physiological and biochemical processes that occur in the human kidney, providing a platform for studying kidney function, drug toxicity, and disease mechanisms.
Published Date: 2024-02-23
Pages: 105
USD 2900.00
(Single User License)
Global Kidney-Organ Chip Market Insights, Forecast to 2030
A Kidney-Organ Chip, often referred to as a "kidney chip," is a microfluidic device designed to replicate the structure and function of the human kidney on a miniature scale. It is a type of organ-on-a-chip technology used in biomedical research and drug development. The Kidney-on-a-Chip model aims to mimic the physiological and biochemical processes that occur in the human kidney, providing a platform for studying kidney function, drug toxicity, and disease mechanisms.
Published Date: 2024-04-26
Pages: 115
USD 4900.00
(Single User License)
Global Kidney-Organ Chip Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Kidney-Organ Chip market is projected to grow from US$ 35.29 million in 2025 to US$ 73.18 million by 2032, at a CAGR of 10.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-08-02
Pages: 124
USD 4900.00
(Single User License)
Kidney-Organ Chip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Kidney-Organ Chip was estimated to be worth US$ 35.29 million in 2025 and is projected to reach US$ 73.18 million, growing at a CAGR of 10.5% from 2026 to 2032.
Published Date: 2026-08-02
Pages: 110
USD 3950.00
(Single User License)
Global Kidney-Organ Chip Market Size, Status and Forecast 2026-2032
The global Kidney-Organ Chip market was valued at US$ 35.29 million in 2025 and is anticipated to reach US$ 73.18 million by 2032, at a CAGR of 10.5% from 2026 to 2032.
Published Date: 2026-08-02
Pages: 104
USD 2900.00
(Single User License)
Global Kidney-Organ Chip Market Research Report 2024
A Kidney-Organ Chip, often referred to as a "kidney chip," is a microfluidic device designed to replicate the structure and function of the human kidney on a miniature scale. It is a type of organ-on-a-chip technology used in biomedical research and drug development. The Kidney-on-a-Chip model aims to mimic the physiological and biochemical processes that occur in the human kidney, providing a platform for studying kidney function, drug toxicity, and disease mechanisms.
Published: 2024-02-23
Pages: 105
USD 2900.00 (Single User License)Global Kidney-Organ Chip Market Insights, Forecast to 2030
A Kidney-Organ Chip, often referred to as a "kidney chip," is a microfluidic device designed to replicate the structure and function of the human kidney on a miniature scale. It is a type of organ-on-a-chip technology used in biomedical research and drug development. The Kidney-on-a-Chip model aims to mimic the physiological and biochemical processes that occur in the human kidney, providing a platform for studying kidney function, drug toxicity, and disease mechanisms.
Published: 2024-04-26
Pages: 115
USD 4900.00 (Single User License)Global Kidney-Organ Chip Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Kidney-Organ Chip market is projected to grow from US$ 35.29 million in 2025 to US$ 73.18 million by 2032, at a CAGR of 10.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-08-02
Pages: 124
USD 4900.00 (Single User License)Kidney-Organ Chip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Kidney-Organ Chip was estimated to be worth US$ 35.29 million in 2025 and is projected to reach US$ 73.18 million, growing at a CAGR of 10.5% from 2026 to 2032.
Published: 2026-08-02
Pages: 110
USD 3950.00 (Single User License)Global Kidney-Organ Chip Market Size, Status and Forecast 2026-2032
The global Kidney-Organ Chip market was valued at US$ 35.29 million in 2025 and is anticipated to reach US$ 73.18 million by 2032, at a CAGR of 10.5% from 2026 to 2032.
Published: 2026-08-02
Pages: 104
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
Key Findings
Market Trends
Market Segmentation
Market Dynamics
Industry Chain Analysis
Segment Insights
Downstream Market Opportunities
Regional Insights
Competitive Landscape Analysis
Report Scope
Chapter Outline
QYResearch's Strengths
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research